Eisai U.S. Alzheimer’s Disease and Brain Health Revenue and Competitors

Eisai U.S. Alzheimer’s Disease and Brain Health aims to revolutionize treatment for some of the world’s most challenging neurological conditions. Our goal is clear: to find solutions that benefit patients, their families, care partners, health care professionals, and society. One way we hope to achieve this is by advancing the most comprehensive pipeline spanning the Alzheimer’s disease biological process. But we are not stopping there. Driven by our human health care (hhc) mission, Eisai is working to improve brain health and ultimately bring forward new solutions that can prevent neurodegeneration before it starts. \n\nFollow us to stay up-to-date on our work in Alzheimer’s disease, sleep-wake disorders, and other neurological issues. Be the first to hear about our latest publications, data updates, symposiums, and breaking news. \n\nFollow us to enjoy scientific content, including publications and symposiums, breaking news, resources for scientists, health care professionals, patients and caregivers, and perspective pieces from experts, patients, and caregivers. We invite you to learn more about our pathophysiology-guided approach and unique human health care (hhc) mission.